Is LBRX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LBRX. It does not provide personalized investment advice.

LBRX (LB Pharmaceuticals Inc Common Stock) Stock Analysis - Financials

LB Pharmaceuticals Inc Common Stock (LBRX) is a publicly traded the market company. As of November 5, 2026, LBRX trades at $38.11 with a market cap of $1.32B and a P/E ratio of -11.05. LBRX moved -6.66% today. Year to date, LBRX is +84.74%; over the trailing twelve months it is +134.46%. Its 52-week range spans $13.36 to $50.16. Analyst consensus is strong buy with an average price target of $60.70. Rallies surfaces LBRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are LBRX's key financials?

LBRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LBRX recently traded at $38.11. Market cap is $1.32B. P/E ratio is -11.05. Revenue is $0.

LBRX Key Metrics

Key financial metrics for LBRX
Metric	Value
Price	$38.11
Market Cap	$1.32B
P/E Ratio	-11.05
EPS	$-3.13
Dividend Yield	0.00%
52-Week High	$50.16
52-Week Low	$13.36
Volume	274.17K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-25.20M
Gross Margin	0.00%

LBRX Analyst Consensus

10 analysts cover LBRX: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $60.70.

Common questions about LBRX

What are LBRX's key financials?: LBRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LBRX recently traded at $38.11. Market cap is $1.32B. P/E ratio is -11.05. Revenue is $0.
Is LBRX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LBRX. It does not provide personalized investment advice.